+
1.
Preclinical evidence suggests that N-acetylcysteine (NAC) exerts its effects on addictive behaviors via what neurotransmitter?
2.
Which of the following statements best describes the trial's efficacy findings?
3.
Which of the following statements is true regarding the trial's safety findings?